Get these health and wellness insights emailed to you three times a week. With our LiveWell app and website, you can manage health and wellness for yourself and for everyone who counts on you.
Scientists at Heriot Watt University developed a cost-effective technique for faster, more accurate prostate cancer detection using ultrasound equipment, with a 94% success rate in early trials.
A groundbreaking technique developed by scientists at Heriot Watt University in Edinburgh, could offer new hope for faster and more accessible prostate cancer detection. Using existing ultrasound ...
High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...
Jan. 15, 2025 — Researchers have designed process that uses ultrasound to modify the behavior of cancer-fighting T cells by increasing their cell permeability. They targeted freshly isolated ...
The cost of an ultrasound scanner is a fraction of an MRI scanner (around 10%), so the new approach provides clinicians with a valuable new tool to help better guide prostate biopsies and focal ...
A man who was diagnosed with cancer twice in just over a year has praised a new non-invasive ultrasound treatment which saved his life after enduring the "hell" of chemotherapy. Stuart Emerson, 60, ...
Q: Is it possible to treat prostate cancer with sound waves? A: High-intensity focused ultrasound is an innovative treatment option for men with localized, low to intermediate-risk prostate cancer.
Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.
Jan. 28, 2025 — The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In ...
Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the clinical ...